DrugPatentWatch Database Preview
BENYLIN Drug Profile
see a sample report or, see our see our flat-rate plans
When do Benylin patents expire, and what generic alternatives are available?
The generic ingredient in BENYLIN is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for BENYLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Bulk Api Vendors: | 75 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,454 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BENYLIN at DailyMed |
Medical Subject Heading (MeSH) Categories for BENYLIN
Synonyms for BENYLIN
| .alpha.-Hydroxydiphenylmethane-.beta.-dimethylaminoethyl ether hydrochloride |
| .beta.-Dimethylaminoethyl benzhydryl ether hydrochloride |
| [2-(diphenylmethoxy)ethyl]dimethylamine hydrochloride |
| [2-(diphenylmethoxy)ethyl]dimethylamine, chloride |
| 147-24-0 |
| 2-(benzhydryloxy)-N,N-dimethylethan-1-amine hydrochloride |
| 2-(benzhydryloxy)-N,N-dimethylethanamine hydrochloride |
| 2-(Benzhydryloxy)-N,N-dimethylethylamine hydrochloride |
| 2-(diphenylmethoxy)-N,N-dimethylethanamine h ydrochloride |
| 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride |
| 2-(Diphenylmethoxy)-N,N-dimethylethylamine hydrochloride |
| 2-[(diphenylmethyl)oxy]-N,N-dimethylethanamine hydrochloride |
| 2-Benz-hydryloxyethyl-N,N-dimethylammonium chloride |
| 2-benzhydryloxy-N,N-dimethyl-ethanamine hydrochloride |
| 2-benzhydryloxy-N,N-dimethylethanamine hydrochloride |
| 2-benzhydryloxy-N,N-dimethylethanamine;hydrochloride |
| 2-benzhydryloxyethyl-N,N-dimethylammonium chloride |
| 2-Diphenylmethoxy-N,N-dimethylethanamine hydrochloride |
| 2-Diphenylmethoxy-N,N-dimethylethylamine hydrochloride |
| 2-Diphenylmethoxy-N,N-dimethylethylamine hydrochloride; N-(2-Diphenylmethoxyethyl)-N,Ndimethylamine hydrochloride |
| 8052-21-9 |
| AB0011241 |
| AB1009368 |
| AC-3449 |
| AC1L1S27 |
| ACMC-209tgi |
| AK157107 |
| AKOS005287308 |
| Allergan |
| Allergival |
| alpha-(2-dimethylaminoethoxy)diphenylmethane hydrochloride |
| alpha-hydroxydiphenylmethane-beta-dimethylaminoethyl ether hydrochlori de |
| alpha-Hydroxydiphenylmethane-beta-dimethylaminoethyl ether hydrochloride |
| Ambenyl |
| AN-12960 |
| ANW-42448 |
| ARONIS25348 |
| AS-12088 |
| Asdrin |
| Bayer Select Night Time Pain Relief |
| BC205545 |
| Bena |
| Benadril hydrochloride |
| Benadryl (TN) |
| Benadryl hydrochloride |
| Benadryl Preservative Free |
| Bendylate |
| Benocten |
| Benzantin |
| Benzantin hydrochloride |
| Benzehist |
| Benzhydramine HCl |
| Benzhydramine hydrochloride |
| Benzhydramine hydrochloride; 2-(Benzhydryloxy)-N,N-dimethylethylamine hydrochloride; N-(2-Diphenylmethoxyethyl)-N,N-dimethylamine hydrochloride |
| Benzhydrol, beta-dimethylaminoethyl ether hydrochloride |
| beta-Dimethylaminoethanol diphenylmethyl ether hydrochloride |
| beta-dimethylaminoethyl benzhydryl ether hydroch loride |
| beta-Dimethylaminoethyl benzhydryl ether hydrochloride |
| C07784 |
| Caladryl |
| Carphenamine |
| Carphenex |
| CAS-147-24-0 |
| Cathejell |
| CCG-39755 |
| CCRIS 2383 |
| CHEBI:4637 |
| CHEMBL1620 |
| component of Bena-Fedrin |
| component of Caladryl |
| CPD000058353 |
| CS-2340 |
| CTK3J2554 |
| D 3630 |
| D00669 |
| D0423 |
| Daedalon |
| Denydryl |
| difenhydramine h ydrochloride |
| Difenhydramine hydrochloride |
| Dimedrol |
| Dimedrol hydrochloride |
| Dimedrol-hydrochloride |
| Dimedrolum |
| Dimethylamine benzhydryl ester hydrochloride |
| Diphamine |
| Diphenhydramine (hydrochloride) |
| Diphenhydramine HCl |
| Diphenhydramine HCl (Benadryl) |
| Diphenhydramine Hcl Preservative Free |
| DIPHENHYDRAMINE HYDROCHLORIDE |
| Diphenhydramine hydrochloride (JP17/USP) |
| Diphenhydramine hydrochloride [BAN:JAN] |
| Diphenhydramine hydrochloride [USP:BAN:JAN] |
| Diphenhydramine Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Diphenhydramine hydrochloride preservative free |
| Diphenhydramine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
| Diphenhydramine hydrochloride, >=98% (HPLC) |
| Diphenhydramine hydrochloride, analytical standard |
| Diphenhydramine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Diphenhydramine hydrochloride, pharmaceutical secondary standard; traceable to USP and PhEur |
| Diphenhydramine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Diphenhydramine, hydrochloride |
| Diphenhydramine.HCl |
| Diphenydramine hydrochloride |
| Diphenylhydramine hydrochloride |
| Dipjemhist |
| Dobacen hydrochloride |
| DSSTox_CID_537 |
| DSSTox_GSID_20537 |
| DSSTox_RID_75646 |
| DTXSID4020537 |
| EBD1627 |
| EINECS 205-687-2 |
| Eldadryl |
| Ethanamine, 2-(diphenylmet hoxy)-N,N,dimethyl-, hydrochloride |
| Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride |
| Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride (1:1) |
| Ethanamine, 2-(diphenylmethoxy)-N,N,dimethyl-, hydrochloride |
| ETHANAMINE,2-[DI(PHENYL-D5)METHOXY]-N,N-DIMETHYL-, HYDROCHLORIDE (9CI) |
| Ethylamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride |
| Ethylamine,N-dimethyl-2-(diphenylmethoxy)-, hydrochloride |
| EU-0100377 |
| Felben |
| Fenylhist |
| FT-0652576 |
| Halbmond |
| Histacyl |
| HMS1568M11 |
| HMS1920I06 |
| HY-B0303A |
| Hydryllin |
| Jsp002743 |
| KS-00000X1C |
| KS-0000477U |
| KSC492K5J |
| LP00377 |
| LS-67 |
| MCULE-3867814648 |
| MFCD00012479 |
| MLS000028428 |
| MLS000758216 |
| MLS001148114 |
| MLS001423951 |
| MLS002222180 |
| MolPort-000-837-708 |
| N-(2-Diphenylmethoxyethyl)-N,N-dimethylamine hydrochloride |
| N-(2-Diphenylmethoxyethyl)-N,N-dimethylaminehydrochloride |
| N-[2-Diphenylmethoxyethyl]-N,N-dimethylamine |
| N,N-dimethyl-2-(diphenylmethoxy)ethylamine hydrochloride |
| NC00060 |
| NCGC00015335-09 |
| NCGC00024414-05 |
| NCGC00093809-01 |
| NCGC00093809-02 |
| NCGC00093809-03 |
| NCGC00093809-04 |
| NCGC00093809-05 |
| NCGC00254264-01 |
| NCGC00259023-01 |
| NCGC00261062-01 |
| NCI-C56075 |
| Noctomin |
| NSC 33299 |
| NSC-33299 |
| NSC-756729 |
| NSC33299 |
| NSC756729 |
| O-benzhydryldimethylaminoethanol hydrochloride |
| Opera_ID_152 |
| OR140485 |
| OR222689 |
| Paradryl |
| PCHPORCSPXIHLZ-UHFFFAOYSA-N |
| Pharmakon1600-01500256 |
| Prestwick_177 |
| Prodryl |
| Q-201003 |
| REGID_for_CID_8980 |
| Resmin |
| Restamin |
| Rohydra |
| RTX-012323 |
| s1866 |
| SAM001247024 |
| SC-80236 |
| SCHEMBL17071 |
| Se dopretten |
| Secundal-D |
| Sedopretten |
| Sekundal-D |
| SK-Diphenhydramine |
| Sleep-Eze-3 |
| SMR000058353 |
| SPECTRUM1500256 |
| ST24039533 |
| ST45054142 |
| ST50319979 |
| TC2D6JAD40 |
| TL8001037 |
| Tox21_112991 |
| Tox21_201472 |
| Tox21_300611 |
| Tox21_500377 |
| Tylenol Cold Night Time Liquid |
| Tylenol PM Tablets/Caplets |
| UNII-TC2D6JAD40 |
| Valdrene |
| Vena |
| Vicks Formula 44 |
| Wehydryl |
| WLN: 1N1 & 2OYR & R & GH |
| Ziradryl |
US Patents and Regulatory Information for BENYLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | BENYLIN | diphenhydramine hydrochloride; pseudoephedrine hydrochloride | SOLUTION;ORAL | 019014-001 | Jun 11, 1985 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Parke Davis | BENYLIN | diphenhydramine hydrochloride | SYRUP;ORAL | 006514-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
